Crossref
Are we ready to change our surveillance strategy for primary sclerosing cholangitis patients?
Endoscopy · 01.05.2025 · 57 (05) · 441-442
DOI: 10.1055/a-2541-3986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.05.2025. Verfasst von Arnaud Lemmers. Beteiligte Einrichtung: Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles (HUB), CUB Erasme Hospital, Universite…. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Hôpital Universitaire de Bruxelles (HUB), CUB Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium.
ORCID-Profile: Arnaud Lemmers
Zitieren
APA
Lemmers, A. (2025). Are we ready to change our surveillance strategy for primary sclerosing cholangitis patients?. Endoscopy, 57(05), 441-442. https://doi.org/10.1055/a-2541-3986
Vancouver
Lemmers A. Are we ready to change our surveillance strategy for primary sclerosing cholangitis patients?. Endoscopy. 2025;57(05):441-442. doi:10.1055/a-2541-3986
BibTeX
@article{Lemmers2025,
author = {Lemmers, Arnaud},
title = {Are we ready to change our surveillance strategy for primary sclerosing cholangitis patients?},
journal = {Endoscopy},
year = {2025},
volume = {57},
number = {05},
pages = {441--442},
doi = {10.1055/a-2541-3986}
}
EUVIMED